These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31941795)

  • 21. [The application of n-acetylcysteine as an antioxidant and mucolytic in mechanical ventilation in intensive care patients. A prospective, randomized, placebo-controlled, double-blind study].
    Konrad F; Schoenberg MH; Wiedmann H; Kilian J; Georgieff M
    Anaesthesist; 1995 Sep; 44(9):651-8. PubMed ID: 7485927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of N-acetylcysteine supplementation on oxidative stress status and alveolar inflammation in people exposed to asbestos: a double-blind, randomized clinical trial.
    Alfonso H; Franklin P; Ching S; Croft K; Burcham P; Olsen N; Reid A; Joyce D; de Klerk N; Musk AB
    Respirology; 2015 Oct; 20(7):1102-7. PubMed ID: 26172395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetylcysteine for therapy-resistant tobacco use disorder: a pilot study.
    Prado E; Maes M; Piccoli LG; Baracat M; Barbosa DS; Franco O; Dodd S; Berk M; Vargas Nunes SO
    Redox Rep; 2015 Sep; 20(5):215-22. PubMed ID: 25729878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge's disease).
    Sharma S; Gralla J; Ordonez JG; Hurtado ME; Swenson ER; Schoene RB; Kelly JP; Callacondo D; Rivard C; Roncal-Jimenez C; Sirota J; Fuquay R; Jackson BP; Swenson KE; Johnson RJ; Hurtado A; Escudero E
    Respir Physiol Neurobiol; 2017 Dec; 246():1-8. PubMed ID: 28720395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alcohol use during a trial of N-acetylcysteine for adolescent marijuana cessation.
    Squeglia LM; Baker NL; McClure EA; Tomko RL; Adisetiyo V; Gray KM
    Addict Behav; 2016 Dec; 63():172-7. PubMed ID: 27521979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ryanodine Receptor 1-Related Myopathies: Quantification of Intramuscular Fatty Infiltration from T1-Weighted MRI.
    Lawal TA; Patankar A; Todd JJ; Razaqyar MS; Chrismer IC; Zhang X; Waite MR; Jain MS; Emile-Backer M; Witherspoon JW; Liu CY; Grunseich C; Meilleur KG
    J Neuromuscul Dis; 2021; 8(4):657-668. PubMed ID: 33646171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-clinical evaluation of N-acetylcysteine reveals side effects in the mdx mouse model of Duchenne muscular dystrophy.
    Pinniger GJ; Terrill JR; Assan EB; Grounds MD; Arthur PG
    J Physiol; 2017 Dec; 595(23):7093-7107. PubMed ID: 28887840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, blinded, placebo-controlled clinical trial of N-acetylcysteine in dogs with spinal cord trauma from acute intervertebral disc disease.
    Baltzer WI; McMichael MA; Hosgood GL; Kerwin SC; Levine JM; Steiner JM; Ruaux CG
    Spine (Phila Pa 1976); 2008 Jun; 33(13):1397-402. PubMed ID: 18520934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes.
    Liu Y; Lei S; Gao X; Mao X; Wang T; Wong GT; Vanhoutte PM; Irwin MG; Xia Z
    Clin Sci (Lond); 2012 Feb; 122(4):161-73. PubMed ID: 21892921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-diagnostic urinary 15-F
    Ma X; Tan YT; Yang Y; Gao J; Li HL; Zheng W; Lan Q; Rothman N; Shu XO; Xiang YB
    Int J Cancer; 2018 Oct; 143(8):1896-1903. PubMed ID: 29756347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
    Nikoo M; Radnia H; Farokhnia M; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2015; 38(1):11-7. PubMed ID: 25580916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
    Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
    Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical significance of plasma free 15-F2t-isoprostane concentration during coronary artery bypasses graft surgery].
    Huang ZY; Xia ZY; Ansley DM; Dhaliwal BS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Mar; 16(3):165-8. PubMed ID: 15009967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).
    Dworski R; Roberts LJ; Murray JJ; Morrow JD; Hartert TV; Sheller JR
    Clin Exp Allergy; 2001 Mar; 31(3):387-90. PubMed ID: 11260149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma 8-isoprostane is increased in preterm infants who develop bronchopulmonary dysplasia or periventricular leukomalacia.
    Ahola T; Fellman V; Kjellmer I; Raivio KO; Lapatto R
    Pediatr Res; 2004 Jul; 56(1):88-93. PubMed ID: 15128912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant N-acetylcysteine attenuates the reduction of Brg1 protein expression in the myocardium of type 1 diabetic rats.
    Xu J; Lei S; Liu Y; Gao X; Irwin MG; Xia ZY; Hei Z; Gan X; Wang T; Xia Z
    J Diabetes Res; 2013; 2013():716219. PubMed ID: 23853776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The effect of prophylactically administered n-acetylcysteine on clinical indicators for tissue oxygenation during hyperoxic ventilation in cardiac risk patients].
    Spies C; Giese C; Meier-Hellmann A; Specht M; Hannemann L; Schaffartzik W; Reinhart K
    Anaesthesist; 1996 Apr; 45(4):343-50. PubMed ID: 8702052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vitamin E supplementation and plasma 8-isoprostane and adiponectin in overweight subjects.
    Sutherland WH; Manning PJ; Walker RJ; de Jong SA; Ryalls AR; Berry EA
    Obesity (Silver Spring); 2007 Feb; 15(2):386-91. PubMed ID: 17299112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
    Kasielski M; Nowak D
    Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial.
    Kay J; Chow WH; Chan TM; Lo SK; Kwok OH; Yip A; Fan K; Lee CH; Lam WF
    JAMA; 2003 Feb; 289(5):553-8. PubMed ID: 12578487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.